I. In this section:
(a)"Administer" means the direct application of epinephrine to the body of an individual.
(b)"Authorized entity" means any entity or organization in which allergens capable of causing anaphylaxis may be present, including recreation camps and day care facilities. Authorized entity shall not include an elementary or secondary school or a postsecondary educational institution eligible to establish policies and guidelines for the emergency administration of epinephrine under RSA 200-N.
(c)"Health care practitioner" means a person who is lawfully entitled to prescribe, administer, dispense, or distribute controlled drugs.
(d)"Provide" means to furnish one or more doses of epinephrine to an individual.
II. A health care practitioner may prescribe epinephrine in the name
Free access — add to your briefcase to read the full text and ask questions with AI
I. In this section:
(a) "Administer" means the direct application of epinephrine to the body of an individual.
(b) "Authorized entity" means any entity or organization in which allergens capable of causing anaphylaxis may be present, including recreation camps and day care facilities. Authorized entity shall not include an elementary or secondary school or a postsecondary educational institution eligible to establish policies and guidelines for the emergency administration of epinephrine under RSA 200-N.
(c) "Health care practitioner" means a person who is lawfully entitled to prescribe, administer, dispense, or distribute controlled drugs.
(d) "Provide" means to furnish one or more doses of epinephrine to an individual.
II. A health care practitioner may prescribe epinephrine in the name of an authorized entity for use in accordance with this section, and pharmacists and health care practitioners may dispense epinephrine pursuant to a prescription issued in the name of an authorized entity.
III. An authorized entity may acquire and maintain a supply of epinephrine pursuant to a prescription issued in accordance with this section. Such epinephrine shall be stored in a location readily accessible in an emergency and in accordance with the instructions for use, and any additional requirements that may be established by the board of medicine. An authorized entity shall designate employees or agents who have completed the training required by paragraph V to be responsible for the storage, maintenance, control, and general oversight of epinephrine acquired by the authorized entity.
IV. An employee or agent of an authorized entity, or other individual, who has completed the training required by paragraph V may use epinephrine pursuant to this section to:
(a) Provide epinephrine to any individual who the employee agent or other individual believes in good faith is experiencing anaphylaxis, or the parent, guardian, or caregiver of such individual, for immediate administration, regardless of whether the individual has a prescription for epinephrine or has previously been diagnosed with an allergy.
(b) Administer epinephrine to any individual who the employee, agent, or other individual believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for epinephrine or has previously been diagnosed with an allergy.
V. (a) An employee, agent, or other individual described in paragraph IV shall complete an anaphylaxis training program at least every 2 years, following completion of the initial anaphylaxis training program. Such training shall be conducted by a nationally-recognized organization experienced in training unlicensed persons in emergency health care treatment or an entity or individual approved by the board of medicine. Training may be conducted online or in person and, at a minimum, shall cover:
(1) How to recognize signs and symptoms of severe allergic reactions, including anaphylaxis;
(2) Standards and procedures for the storage and administration of epinephrine ; and
(3) Emergency follow-up procedures.
(b) The entity or individual that conducts the training shall issue a certificate, on a form developed or approved by the board of medicine to each person who successfully completes the anaphylaxis training program.
VI. No authorized entity that possesses and makes available epinephrine and its employees, agents, and other individuals, or health care practitioner that prescribes or dispenses epinephrine to an authorized entity, or pharmacist or health care practitioner that dispenses epinephrine to an authorized entity, or individual or entity that conducts the training described in paragraph V, shall be liable for any injuries or related damages that result from any act or omission pursuant to this section, unless such injury or damage is the result of willful or wanton misconduct. The administration of epinephrine in accordance with this section shall not be considered to be the practice of medicine or any other profession that otherwise requires licensure. This section shall not be construed to eliminate, limit, or reduce any other immunity or defense that may be available under state law. An entity located in this state shall not be liable for any injuries or related damages that result from the provision or administration of epinephrine outside of this state if the entity would not have been liable for such injuries or related damages had the provision or administration occurred within this state, or is not liable for such injuries or related damages under the law of the state in which such provision or administration occurred.